Erin McEvoy

Articles

The Senate recently passed a bill that would enable veterans to discuss and be recommended medical cannabis by Veterans Affairs doctors.

Senate Approves Bill That Would Allow Medical Cannabis Recommendations from Veterans Affairs Doctors

The recent statement highlighted a lack of research, provides recommendations, and called for unbiased education for clinicians.

 Canadian Paediatric Society Publishes Recommendations on Medical Cannabis Use in Children

The 18-month trial will study the effects of a cannabis extract as part of treatment for brain cancer.

Clinical Trial in Spain Will Investigate the Role of Cannabis in Glioblastoma Treatment

Patient access to medical cannabis will increase greatly in the coming weeks.

Georgia Pharmacies Approved to Carry Medical Cannabis

Americans for Safe Access, the nation’s largest member-based medical cannabis advocacy organization, held a webinar discussing the recent recommendation made by the Department of Health and Human Services to reschedule cannabis.

The Knowns and Unknowns: Americans for Safe Access Discusses Cannabis Scheduling and its Potential Impacts on Patients

Madeline Colli is the Associate Editor for Cannabis Patient Care and Cannabis Science and Technology magazines at MJH Life Sciences.

On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way for reform, industry expansion, and research opportunities.

Shifting Tides: US Department of Health and Human Services Recommends Cannabis Rescheduling from Schedule I to Schedule III

Cannabis Science Conference (CSC) Fall will be taking place in Providence, Rhode Island September 20-22nd. CSC Fall features several exciting tracks: analytical science, cultivation, medical cannabis, and psychedelics. With expert speakers coming in from around the country, we thought it was a great opportunity to introduce some of them and get a sneak peek into their presentations. Let’s meet Amanda Reiman, PhD, Chief Knowledge Officer at New Frontier Data, an analytics company serving the legal cannabis industry. Dr. Reiman has been studying the relationship between cannabis, people, and society for more than 20 years. She earned her PhD in social welfare from UC Berkeley, and conducted one of the first studies of medical cannabis patients. Dr. Reiman will be presenting a talk titled “Patient Profiles: Characteristics of a Large Sample of Medical Cannabis Patients” in the medical track on Thursday, September 21st. Here, Dr. Reiman shares her background in medical cannabis, some of her research efforts, and a preview of her upcoming talk. 

Meet the Cannabis Science Conference Fall Speakers: Dr. Amanda Reiman on Medical Cannabis Patient Profiles and Research 

Learn more about how our Canna Boot Camp will educate attendees on the latest advancements in the cannabis industry in an interactive, workshop setting.

Cannabis Science Conference Announces Mother Earth Wellness as Host of the Fall 2023 Canna Boot Camp

Hear more from Kim Stuck, author of the Cannabis Science and Technology blog Stuck on Compliance, share how cannabis helped her maintain weight and manage pain during chemotherapy. 

How Cannabis Helped This Survivor During Breast Cancer Treatment

Americans for Safe Access, the nation’s largest member-based organization promoting safe access to medical cannabis, recently released a detailed report on how disparities in state cannabis testing programs affect the health of patients.